KIT and medium chain acyl-CoA dehydrogenase deficiency: (2) In our comparative analysis of KIT mutations in mast cells from patients with MCAD and control subjects we detected potentially functionally activating genetic alterations in 13 of 20 patients (65%) and in 3 of 20 control subjects (15%) [22].